Rapid Medical Diagnostic Kits Market by Diagnostic Technologies or Assays – Latex Agglutination Assays, Flow-Through Assays, Lateral Flow Immunoassays (Immunochromatographic Strip Tests), Solid-Phase Assays, and Medical Applications (Hospitals, Labs or Clinical and Home Based Testing – Blood Glucose, Infection, Cholesterol, Fertility and Pregnancy, Substance of Abuse, and Veterinary Testing) and Forecast 2017-2021

Rapid Medical Diagnostic Kits Market by Diagnostic Technologies or Assays – Latex Agglutination Assays, Flow-Through Assays, Lateral Flow Immunoassays (Immunochromatographic Strip Tests), Solid-Phase Assays, and Medical Applications (Hospitals, Labs or Clinical and Home Based Testing – Blood Glucose, Infection, Cholesterol, Fertility and Pregnancy, Substance of Abuse, and Veterinary Testing) and Forecast 2017-2021

Rapid Diagnostic Tests (RDTs) are diagnostic assays designed for use at the point-of-care (POC), and can be adapted for use in low-resource settings. An RDT is low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time. Rapidly growing medical diagnostics industry, higher demand for preventive management of infectious diseases caused by virus and bacteria worldwide are some of the factors contributing to the growth of global rapid medical diagnostic testing kits market. Rapid medical diagnostics is used for detection of various infectious diseases, caused diabetes, measuring cholesterol levels, testing drug abuse and pregnancy testing.

The global rapid medical diagnostic kits market report estimates the market size (Revenue USD million – 2014 to 2021) for market segmentation based on diagnostic technologies or assays such as latex agglutination assays, flow-through assays, lateral flow immunoassays (immunochromatographic strip tests), solid-phase assays and their medical applications (hospitals, labs or clinical and home based testing – blood glucose, infection, cholesterol, fertility and pregnancy, substance of abuse, and veterinary testing), and forecasts growth trends (CAGR% – 2017 to 2021).

The global rapid medical diagnostic kits market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global rapid medical diagnostic kits market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global rapid medical diagnostic kits market and included in this report are Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton Dickinson and Company, BioRad Laboratories, F. Hoffmann La Roche, MegaCor, Trinity Biotech, Zoetis, Inc.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Diagnostic Test Type
    • Indication or Infection Type
    • Technology
    • Diagnostics Application
    • Service Type
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Rapid Diagnostic Testing (RDT) Kits Market

1. Diagnostic Assays
1.1. Flow-through Assays
1.2. Lateral Flow Immunoassays
1.3. Latex agglutination Assays
1.4. Solid-Phase Assays

2. Medical Application
2.1. Hospital Testing
2.1.1. Blood Glucose Testing
2.1.2. Cholesterol Monitoring
2.1.3. Fertility & Pregnancy Testing
2.1.4. Infectious Disease Testing
2.1.5. Substance Abuse Testing
2.2. Labs or Clinical Testing
2.2.1. Blood Glucose Testing
2.2.2. Cholesterol Monitoring
2.2.3. Fertility & Pregnancy Testing
2.2.4. Infectious Disease Testing
2.2.5. Substance Abuse Testing
2.3. Home Based
2.3.1. Blood Glucose Testing
2.3.2. Cholesterol Monitoring
2.3.3. Fertility & Pregnancy Testing
2.3.4. Infectious Disease Testing
2.3.5. Substance Abuse Testing
2.4. Veterinary Testing

3. Company Profiles
3.1. Abaxis, Inc.
3.2. Abbott Laboratories, Inc.
3.3. Alere, Inc.
3.4. Becton, Dickinson & Company
3.5. Bio-Rad Laboratories, Inc.
3.6. Danaher Corporation (Beckman Coulter)
3.7. F. Hoffmann-La Roche Ltd.
3.8. MegaCor Diagnostik GmbH
3.9. Trinity Biotech plc.
3.10. Zoetis, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*